Skip to main content
Premium Trial:

Request an Annual Quote

Bruker's Revenues Jump 27 Percent in Q4 as Service and Product Sales Up

NEW YORK (GenomeWeb News) — Bruker BioSciences today said fourth-quarter revenues increased 27 percent as R&D spending rose 23 percent and profit nearly doubled.
Total receipts for the three months ended Dec. 31, 2006, increased to $135.6 million from $106.7 million year over year.
Product revenue increased 25 percent to $120.4 million; service revenue increased 45 percent to $15 million; and “other” revenue decreased 48 percent to $146,000.
CEO Frank Laukien said the acquisition of Bruker Optics and other expansions added to revenue for the year. He said the company “continued to strengthen both our traditional research systems business and our newer industrial and applied analysis business,” and added that the fourth quarter was “particularly strong.”
Bruker said profit surged 98 percent to $9.7 million from $4.9 million in the year-ago period.
Bruker said it had around $52.7 million in cash and equivalents and short-term investments as of Dec. 31.
Laukien said the company expects revenue to grow more than 10 percent in 2007.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.